Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of experimental & clinical cancer research : CR

• Publication date

  2004-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15595626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Type 1 IGF receptor in human breast diseases

  2005cited by this paper
• Estrogen and Progestin Regulation of Cell Cycle Progression

  2004cited by this paper
• In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase.

  2004cited by this paper
• Function of the IGF-I Receptor in Breast Cancer

  2004cited by this paper
• Crosstalk Between the Insulin-Like Growth Factors and Estrogens in Breast Cancer

  2004cited by this paper
• Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor

  2003cited by this paper
• Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells.

  2003cited by this paper
• Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.

  2003cited by this paper
• Role of the IGF‐I receptor in the regulation of cell–cell adhesion: Implications in cancer development and progression

  2003cited by this paper
• IGF-1 in gynaecology and obstetrics: update 2002.

  2002cited by this paper
• Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.

  2002cited by this paper
• Insulin-like growth factors and cancer.

  2002cited by this paper
• Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.

  2002cited by this paper
• The protein kinase B/Akt signalling pathway in human malignancy.

  2002cited by this paper
• Insulin-like growth factors and prostate cancer

  2001cited by this paper
• Energy balance and cancer: the role of insulin and insulin-like growth factor-I

  2001cited by this paper
• Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

  2001cited by this paper
• Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

  2001cited by this paper
• Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines

  2001cited by this paper
• IGF-I receptor signalling in transformation and differentiation

  2001cited by this paper
• Regulation of Id Gene Expression by Type I Insulin-Like Growth Factor: Roles of STAT3 and the Tyrosine 950 Residue of the Receptor

  2001cited by this paper
• Transcriptional Repression by Rb-E2F and Regulation of Anchorage-Independent Survival

  2001cited by this paper
• IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition

  2001cited by this paper
• American Institute for Cancer Research 11th Annual Research Conference on Diet, Nutrition and Cancer Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence

  2001cited by this paper
• The IGF system and breast cancer.

  2001cited by this paper
• IRS proteins and beta-cell function.

  2001cited by this paper
• Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells

  2001cited by this paper
• IGF-I Receptor-induced Cell-Cell Adhesion of MCF-7 Breast Cancer Cells Requires the Expression of Junction Protein ZO-1*

  2001cited by this paper
• Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways.

  2001cited by this paper
• Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma.

  2001cited by this paper
• Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

  2001cited by this paper
• Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.

  2001cited by this paper
• Anti-apoptotic Signaling of the Insulin-like Growth Factor-I Receptor through Mitochondrial Translocation of c-Raf and Nedd4*

  2001cited by this paper
• Estrogen receptor (ER)-alpha, but not ER-beta, mediates regulation of the insulin-like growth factor I gene by antiestrogens.

  2001cited by this paper
• Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.

  2001cited by this paper
• Estrogens and cell-cycle regulation in breast cancer.

  2001cited by this paper
• Identification of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 as Signaling Intermediates in the α6β4 Integrin-Dependent Activation of Phosphoinositide 3-OH Kinase and Promotion of Invasion

  2001cited by this paper
• Insulin/Insulin-like Growth Factor-I and Estrogen Cooperate to Stimulate Cyclin E-Cdk2 Activation and Cell Cycle Progression in MCF-7 Breast Cancer Cells through Differential Regulation of Cyclin E and p21WAF1/Cip1 *

  2001cited by this paper
• Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells.

  2001cited by this paper
• Quantification of estrogen receptor α and β expression in sporadic breast cancer

  2001cited by this paper
• The IGF axis and hepatocarcinogenesis

  2001cited by this paper
• Id2 Is a Target of the β-Catenin/T Cell Factor Pathway in Colon Carcinoma*

  2001cited by this paper
• Estrogen Receptor (ER)-α, but Not ER-β, Mediates Regulation of the Insulin-like Growth Factor I Gene by Antiestrogens*

  2001cited by this paper
• Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and β-Catenin Pathways

  2001cited by this paper
• Insulin-like growth factor physiology and cancer risk.

  2000cited by this paper
• Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway*

  2000cited by this paper
• Structure and function of the type 1 insulin-like growth factor receptor

  2000cited by this paper
• Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells.

  2000cited by this paper
• Tyrosine kinase signalling in breast cancer: Insulin-like growth factors and their receptors in breast cancer

  2000cited by this paper
• Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor.

  2000cited by this paper
• Mechanism of STAT3 Activation by Insulin-like Growth Factor I Receptor*

  2000cited by this paper
• Insulin Receptor Substrate-1 Expression Is Regulated by Estrogen in the MCF-7 Human Breast Cancer Cell Line*

  2000cited by this paper
• GSK-3: new thoughts on an old enzyme.

  2000cited by this paper
• Regulation of survival signals from the insulin-like growth factor-I receptor.

  2000cited by this paper
• Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

  2000cited by this paper
• Control of β‐Catenin Signaling in Tumor Development

  2000cited by this paper
• Down‐regulation of insulin‐like growth factor‐I receptor and insulin receptor substrate‐1 expression in advanced human breast cancer

  2000cited by this paper
• Control of beta-catenin signaling in tumor development.

  2000cited by this paper
• The Potentiation of Estrogen on Insulin-like Growth Factor I Action in MCF-7 Human Breast Cancer Cells Includes Cell Cycle Components*

  2000cited by this paper
• The contradictions of the insulin-like growth factor 1 receptor

  2000cited by this paper
• Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.

  1999cited by this paper
• Signaling through beta-catenin and Lef/Tcf.

  1999cited by this paper
• Insulin‐like growth factor (IGF)‐I rescues breast cancer cells from chemotherapy‐induced cell death – proliferative and anti‐apoptotic effects

  1999cited by this paper
• Phosphorylation of Human Estrogen Receptor α by Protein Kinase A Regulates Dimerization

  1999cited by this paper
• Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.

  1999cited by this paper
• IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells.

  1999cited by this paper
• Normal growth and development in the absence of hepatic insulin-like growth factor I.

  1999cited by this paper
• Insulin-Like Growth Factor System in Neuroblastoma Tumorigenesis and Apoptosis: Potential Diagnostic and Therapeutic Perspectives

  1999cited by this paper
• Signaling through β-catenin and Lef/Tcf

  1999cited by this paper
• Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis

  1999cited by this paper
• Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.

  1999cited by this paper
• The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.

  1999cited by this paper
• SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility.

  1999cited by this paper
• The IGF-I receptor in cancer research.

  1999cited by this paper
• Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells

  1999cited by this paper
• A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.

  1998cited by this paper
• Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

  1998cited by this paper
• Insulin Receptor Substrate-1 is the Predominant Signaling Molecule Activated by Insulin-like Growth Factor-I, Insulin, and Interleukin-4 in Estrogen Receptor-positive Human Breast Cancer Cells*

  1998cited by this paper
• Type I insulin-like growth factor receptor function in breast cancer

  1998cited by this paper
• The IRS-signalling system: A network of docking proteins that mediate insulin action

  1998cited by this paper
• Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression.

  1998cited by this paper
• Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.

  1998cited by this paper
• Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth*

  1998cited by this paper
• Molecular markers of IGF-I-mediated mitogenesis.

  1998cited by this paper
• Role of growth factors in pancreatic cancer.

  1998cited by this paper
• Differential Regulation of Focal Adhesion Kinase and Mitogen‐Activated Protein Kinase Tyrosine Phosphorylation During Insulin‐Like Growth Factor‐I‐Mediated Cytoskeletal Reorganization

  1998cited by this paper
• Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.

  1997cited by this paper
• The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number.

  1997cited by this paper
• Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.

  1997cited by this paper
• Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.

  1997cited by this paper
• Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.

  1997cited by this paper
• Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.

  1997cited by this paper
• Insulin-like growth factor binding proteins and their role in controlling IGF actions.

  1997cited by this paper
• The localization of the insulin‐like growth factor receptor 1 (IGFR‐1) in benign and malignant breast tissue

  1997cited by this paper
• Insulin‐like Growth Factor‐I (IGF‐I) Receptors in Breast Cancer

  1996cited by this paper
• The adaptor protein Shc couples a class of integrins to the control of cell cycle progression.

  1996cited by this paper
• M6P/IGF2 receptor: a candidate breast tumor suppressor gene.

  1996cited by this paper
• The Roles of Integrins and Extracellular Matrix Proteins in the Insulin-like Growth Factor I-stimulated Chemotaxis of Human Breast Cancer Cells (*)

  1996cited by this paper
• Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors.

  1995cited by this paper
• Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase

  1995cited by this paper

• The Role of Cow’s Milk Consumption in Breast Cancer Initiation and Progression

  2023cites this paper
• Low activation of Insulin-Growth Factor 1-Receptor (IGF1R) is associated with local recurrence in early breast carcinoma

  2023cites this paper
• Investigation of the Interplay between Circulating Lipids and IGF-I and Relevance to Breast Cancer Risk: An Observational and Mendelian Randomization Study

  2021cites this paper
• Mammogenesis Effect of Hot Aqueous Extract of Mentha spicata Leaves on Mammary Tissue of Ovariectimized Rabbits

  2021cites this paper
• Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?

  2021cites this paper
• In-silico modeling and analysis of the therapeutic potential of miRNA-7 on EGFR associated signaling network involved in breast cancer

  2020cites this paper
• Arginine site 264 in murine estrogen receptor alpha is dispensable for the regulation of the skeleton.

  2020cites this paper
• Estimating the effect of lipids on IGF axis and subsequent breast cancer risk

  2020cites this paper
• Estimating the effect of lipids on IGF axis and subsequent breast risk

  2020cites this paper
• Causal associations of autoimmune thyroiditis and papillary thyroid carcinoma: mRNA expression of selected nuclear receptors and other molecular targets.

  2019cites this paper
• Endocrine disruptor actions through receptor crosstalk

  2016cites this paper
• Formal modeling and analysis of ER-α associated Biological Regulatory Network in breast cancer

  2016influential citation
• Dehydron as a Marker for Molecular Evolution: Lessons for the Drug Designer

  2016cites this paper
• Inmunofenotipos de cáncer de mama en pacientes jovenes (40 años o menores): estudio de la expresión inmunohistoquímica de la vía IGF1R, PTEN/Akt/mTOR

  2015cites this paper
• Evolution of Protein Structure Degradation and Lessons for the Drug Designer

  2015cites this paper
• The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study

  2015cites this paper
• Expression of Intratumoral IGF-II Is Regulated by the Gene Imprinting Status in Triple Negative Breast Cancer from Vietnamese Patients

  2015cites this paper
• Computational Methods for Breast Cancer Diagnosis, Prognosis, and Treatment Prediction

  2014cites this paper
• Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans.

  2014cites this paper
• Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells.

  2014cites this paper
• Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer.

  2013cites this paper
• Molecular Pathology of Breast Cancer

  2013cites this paper
• Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.

  2013cites this paper
• miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines

  2013cites this paper
• Expression and significance of IGF-1 and IGF-1R in thyroid nodules

  2013cites this paper
• Characterisation of the direct antiproliferative effects of a gonadotrophin-releasing hormone analogue

  2012cites this paper
• Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies.

  2012cites this paper
• Insulin-like growth factor-1 promotes wound healing in estrogen-deprived mice: new insights into cutaneous IGF-1R/ERα cross talk.

  2012cites this paper
• Developmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice.

  2012cites this paper
• Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells.

  2012cites this paper
• Nuclear IRS‐1 and cancer

  2012cites this paper
• Luteolin inhibits proliferation induced by IGF-1 pathway dependent ERα in human breast cancer MCF-7 cells.

  2012cites this paper
• GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines

  2011cites this paper
• Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma

  2011cites this paper
• Association of insulin-like growth factor-1 with thyroid nodules.

  2011cites this paper
• Hormonal mechanisms underlying the relationship between obesity and breast cancer.

  2011cites this paper
• Combination of post-transcriptional and post-translational down-regulation of the oestrogen receptor in breast cancer

  2011cites this paper
• Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells.

  2011cites this paper
• Evolution of Protein Wrapping and Implications for the Drug Designer

  2010cites this paper
• Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation.

  2010cites this paper
• Targeting the Insulin-like Growth Factor Receptor-1R Pathway for Cancer Therapy

  2010cites this paper
• Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

  2010cites this paper
• Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

  2010influential citation
• Promyelocytic Leukemia Protein Controls Cell Migration in Response to Hydrogen Peroxide and Insulin-like Growth Factor-1*

  2010cites this paper
• Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

  2009cites this paper
• Molecular predictors of response to a humanized anti–insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer

  2009cites this paper
• Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

  2009cites this paper
• Low activation of Insulin-like Growth Factor 1-Receptor (IGF1R) is associated with local recurrence in early breast carcinoma

  2009cites this paper
• Influence of insulin resistance on adiponectin receptor expression in breast cancer.

  2009cites this paper
• Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERα

  2009cites this paper
• The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer

  2008cites this paper
• Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.

  2008cites this paper
• Insulin-dependent leptin expression in breast cancer cells.

  2008cites this paper
• Hormonal heterogeneity of endometrial cancer.

  2008cites this paper
• Leptin — From regulation of fat metabolism to stimulation of breast cancer growth

  2008cites this paper
• Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1.

  2007cites this paper
• The estrogen receptor α:insulin receptor substrate 1 complex in breast cancer: structure–function relationships

  2007cites this paper
• Individualized survival and treatment response predictions for breast cancers using phospho-EGFR, phospho-ER, phospho-HER2/neu, phospho-IGF-IR/In, phospho-MAPK, and phospho-p70S6K proteins.

  2007cites this paper
• Aromatase inhibitors--gene discovery.

  2007cites this paper
• Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study

  2007cites this paper
• The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer.

  2007cites this paper
• Recruitment of insulin receptor substrate-1 and activation of NF-κB essential for midkine growth signaling through anaplastic lymphoma kinase

  2007cites this paper
• Individualized Survival and Treatment Response Predictions for Breast Cancers Using Phospho-EGFR, Phospho-ER, Phospho-HER2/neu, Phospho-IGF-IR/In, Phospho-MAPK, and Phospho-p70S6K Proteins

  2007cites this paper
• Mechanism involved in genistein activation of insulin-like growth factor 1 receptor expression in human breast cancer cells

  2007cites this paper
• Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

  2007cites this paper
• The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships.

  2007cites this paper
• Compensatory mammary growth following protein restriction during pregnancy and lactation increases early-onset mammary tumor incidence in rats.

  2006cites this paper
• Insulin-like growth factor-I receptor signaling and resistance in breast cancer

  2006cites this paper
• Expression of nuclear insulin receptor substrate 1 in breast cancer

  2006cites this paper
• Leptin, estrogens and cancer.

  2006cites this paper
• Insulin-like Growth Factor 1 Differentially Regulates Estrogen Receptor-dependent Transcription at Estrogen Response Element and AP-1 Sites in Breast Cancer Cells*

  2006cites this paper
• The mRNA expression of IGF-1 and IGF-1R in human breast cancer: association with clinico-pathological parameters

  2006cites this paper
• Increased Expression of Leptin and the Leptin Receptor as a Marker of Breast Cancer Progression: Possible Role of Obesity-Related Stimuli

  2006cites this paper
• Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin‐like growth factor receptor type 1

  2006cites this paper
• Is the Type I Insulin-Like Growth Factor Receptor a Therapeutic Target in Endometrial Cancer?

  2006cites this paper
• Modulation of cell cycle components by epigenetic and genetic events.

  2005cites this paper
• Sex steroid-producing enzymes in human breast cancer.

  2005cites this paper
• Breast cancer and pregnancy.

  2005cites this paper